PuriCore Plc Notification of Executive Chairman's Option Grant (5937J)
08 Agosto 2012 - 7:53AM
UK Regulatory
TIDMPURI
RNS Number : 5937J
PuriCore Plc
08 August 2012
8 August 2012
PuriCore plc
("PuriCore" or the "Company")
Notification of Executive Chairman's Option Grant
PuriCore(LSE: PURI), the water-based clean technology company,
today announces that on 7 August 2012 the following options over
Ordinary Shares in the Company were granted to Michael Ashton,
Executive Chairman, under the terms of the PuriCore plc Executive
Omnibus Incentive Plan. These options vest on the second and third
anniversary of the date of grant subject to the achievement of
performance conditions, are exercisable from the date of vesting
until the seventh anniversary of the date of grant and carry an
exercise price of 54 pence per share.
Executive Director Title Options Granted Total Options
Held
Michael Ashton Executive Chairman 200,000 235,000
Enquiries:
UK US
FTI Consulting Sage Strategic Marketing
Susan Stuart Jennifer Guinan
Victoria Foster Mitchell +1 610.410.8111
+44 (0) 20 7831 3113
About PuriCore
PuriCore plc (LSE: PURI) is a water-based clean technology
company focused on developing and commercialising proprietary
solutions that protect people from the spread of infectious
pathogens without causing harm to human health or the environment.
The Company's products are used in a broad range of markets that
depend upon effective pathogen control. PuriCore is the leading
full provider of all products and services required for a safe,
efficient, and compliant endoscope decontamination to protect
patients in UK hospitals. The Company's products are the de facto
standard for food safety in leading US supermarket chains. PuriCore
also offers a breakthrough wound therapy solution to treat chronic
and acute wounds including diabetic ulcers and burns.
PuriCore is headquartered in Malvern, Pennsylvania, with
operations in Stafford and Clevedon, UK. To receive additional
information on PuriCore, please visit our website at
www.puricore.com, which does not form part of this press
release.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUWVURURAWRAR
Realm Thera. (LSE:RLM)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Realm Thera. (LSE:RLM)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Realm Thera. (London Stock Exchange): 0 recent articles
Más de Puricore Artículos de Noticias